亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Method to Expand and Transduce Cultured Human Small and Large Intestinal Stem Cells

技術優勢
Rapid expansion of intestinal stem cells in culture without differentiationAlso permits expansion of stem cells from polyposis disorders, and likely cancer cellsDoes not require a feeder layerResulting tissue can be implanted into humansEfficient genetic manipulation of human cells
技術應用
Use to rapidly expand human small and large intestinal mucosal cells for basic research, therapeutic or toxicological studiesGenetic modification of intestinal stem cells in order to identify important genes Differentiation of intestinal stem cells into implantable tissue as a treatment for intestinal
詳細技術說明
Dr. Martin G. Martin and colleagues have developed novel methods of expanding, differentiating and genetically modifying human small and large intestinal stem cells. Isolated human intestinal stem cells and epithelium have been successfully expanded in culture using a combination of specific conditioned media and inhibitors in order to allow for expansion. The media conditions can then be modified to allow cells to differentiate into mature cell types. Unlike previous methods, this method does not require a feeder layer, and can therefore be transferred into humans once differentiated. Stem cells and epithelium grown in this manner have been successfully transduced with lentiviral vectors, which allows for a range of genetic manipulation including gene-specific knockdown and overexpression.
*Abstract
Dr. Martin G. Martin and colleagues in the Department of Pediatric Gastroenterology and Surgery at UCLA have developed a novel method of expanding and differentiating human small intestinal stem cells in culture.
*Applications
  • Use to rapidly expand human small and large intestinal mucosal cells for basic research, therapeutic or toxicological studies
  • Genetic modification of intestinal stem cells in order to identify important genes 
  • Differentiation of intestinal stem cells into implantable tissue as a treatment for intestinal
*IP Issue Date
Mar 10, 2016
*Principal Investigation

Name: James Dunn

Department:


Name: Martin Martin

Department:


Name: Matthias Stelzner

Department:


Name: Matthias Stelzner

Department:

申請號碼
20160068805
其他

State Of Development

  • Method shown to be robust and reproducible in vitro
  • Investigators are in the process of identifying more specific factors for growth

Background

Stem cells are early progenitor cells that have the potential to self-renew through cell division or to differentiate into specialized mature cell types. Small and large intestine stem cells are somatic stem cells capable of differentiating into all five-cell types found in mature intestine. Ideally, these cells would be expanded in culture, where they could be expanded and genetically manipulated, and then differentiated into mature tissue and transplanted into patients. In order to properly expand stem cells in culture, techniques must be found to expand the cells while maintaining the stem cell qualities that allow them to differentiate into various mature cell types. Current methods of human small and large intestinal stem cell culture have been difficult to reproduce and have a limited capacity to expand in vitro. Therefore, new methods to expand, differentiate and genetically modify human small and large intestinal stem cells are needed.

Tech ID/UC Case

24160/2013-672-0


Related Cases

2013-672-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備